|
GATC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.70819999999661E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.08859999994981E-06 |
| Normal-vs-Stage2 |
8.184800E-03 |
| Normal-vs-Stage3 |
3.765800E-01 |
| Normal-vs-Stage4 |
9.457700E-02 |
| Stage1-vs-Stage2 |
6.304200E-01 |
| Stage1-vs-Stage3 |
2.542500E-02 |
| Stage1-vs-Stage4 |
8.104600E-01 |
| Stage2-vs-Stage3 |
2.650800E-01 |
| Stage2-vs-Stage4 |
9.234200E-01 |
| Stage3-vs-Stage4 |
3.565000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.76569999999332E-05 |
| Normal-vs-AfricanAmerican |
2.961400E-04 |
| Normal-vs-Asian |
2.683500E-02 |
| Caucasian-vs-AfricanAmerican |
5.860800E-01 |
| Caucasian-vs-Asian |
8.131800E-01 |
| AfricanAmerican-vs-Asian |
9.534400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.06359999994122E-07 |
| Normal-vs-Female |
1.650220E-01 |
| Male-vs-Female |
3.562400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.943300E-03 |
| Normal-vs-Extreme_Weight |
5.50490000028603E-07 |
| Normal-vs-Obese |
2.419900E-02 |
| Normal-vs-Extreme_Obese |
1.603880E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.036200E-01 |
| Normal_Weight-vs-Obese |
3.386800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.307600E-01 |
| Extreme_Weight-vs-Obese |
6.023100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.934200E-01 |
| Obese-vs-Extreme_Obese |
2.639000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.791600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.297700E-03 |
| Normal-vs-Age(61-80Yrs) |
4.01989999954111E-07 |
| Normal-vs-Age(81-100Yrs) |
1.021910E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.101600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.020000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.830300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.366100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.301240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.327400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.10320000001884E-06 |
| Normal-VS-Type2 PRCC |
2.676600E-03 |
| Normal-VS-KIRP CIMP |
5.848200E-01 |
| Normal-VS-Unclassified PRCC |
2.665600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.559970E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.739000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.119930E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.554000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.133000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.353600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.10269999999913E-05 |
| Normal-vs-N1 |
5.478600E-01 |
| Normal-vs-N2 |
5.099600E-01 |
| N0-vs-N1 |
2.354000E-02 |
| N0-vs-N2 |
5.669800E-01 |
| N1-vs-N2 |
6.328400E-01 |
|
|
